In this cancer-neuropathy model, the inhibition of TRPV1 and TRPV4 channel activity by their selective antagonists, capsazepine and HC-067047, respectively, transiently reversed the cancer-induced thermal and mechanical allodynia in a dose-dependent manner. The gene discussed is TRPV4; the disease is cancer.